[Vitamin D deficiency in CKD patients]

Area of Science:

• Nephrology
• Endocrinology
• Nutritional Science

Background:

• Vitamin D deficiency and elevated parathyroid hormone (PTH) are prevalent in the general population and particularly in chronic kidney disease (CKD) patients.
• Risk factors for 25-hydroxyvitamin D [25(OH)D] deficiency in CKD include malnutrition, nephrotic syndrome, and limited sun exposure.
• Low serum 25(OH)D in CKD patients leads to reduced calcitriol due to impaired 1-alpha hydroxylase activity, exacerbated by fewer viable nephrons and higher fibroblast growth factor-23 (FGF-23).

Purpose of the Study:

• To highlight the prevalence and contributing factors of vitamin D deficiency in CKD.
• To explain the mechanisms by which vitamin D deficiency impacts calcitriol levels in CKD.
• To suggest the potential broader clinical implications of vitamin D metabolism intervention in CKD.

Main Methods:

• Literature review on vitamin D metabolism in CKD.
• Analysis of factors affecting 25(OH)D levels in CKD patients.
• Discussion of the interplay between vitamin D, PTH, FGF-23, and renal function.

Main Results:

• Vitamin D deficiency is common in CKD, linked to malnutrition, nephrotic syndrome, and low sun exposure.
• CKD impairs the activation of vitamin D to calcitriol, despite elevated PTH.
• Elevated FGF-23 further contributes to low calcitriol levels in CKD.

Conclusions:

• Vitamin D deficiency and its consequences are significant in CKD patients.
• Interventions targeting vitamin D metabolism in CKD may offer benefits beyond bone health.
• Potential impacts on the renin-angiotensin-aldosterone system and insulin resistance warrant further investigation.